US 7378422
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted A61KA61K31/4178A61K31/4439
Quick answer
US patent 7378422 (Inhibitors of serine proteases, particularly HCV NS3-NS4A protease) held by Vertex Pharmaceuticals Incorporated expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/4178, A61K31/4439, A61K31/497, A61K31/501